CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 28, 2007
Clin J Am Soc Nephrol 3: 85-90, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.02570607

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.02570607v1
3/1/85    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pham, N. M.
Right arrow Articles by Meyer, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pham, N. M.
Right arrow Articles by Meyer, T. W.

Dialysis

Removal of the Protein-Bound Solutes Indican and P-Cresol Sulfate by Peritoneal Dialysis

Nhat M. Pham*, Natalie S. Recht*, Thomas H. Hostetter{dagger}, and Timothy W. Meyer*

* Department of Medicine, VA Palo Alto Health Care System, and Stanford University, Palo Alto, California; and {dagger} Department of Medicine, Albert Einstein College of Medicine, New York, New York

Correspondence: Dr. Timothy W. Meyer, Nephrology 111R, Palo Alto VAHCS, 3801 Miranda Avenue, Palo Alto, CA 94303. Phone: 650-852-3314; Fax: 650-852-3411; E-mail: twmeyer{at}stanford.edu

Background and objectives: Protein-bound solutes are poorly cleared by peritoneal dialysis. We examined the hypothesis that plasma concentrations of bound solutes would therefore rise as residual renal function is lost.

Design, setting, participants, & measurements: Clearances of urea indican and p-cresol sulfate were measured in peritoneal dialysis patients with and without residual function.

Results: In patients with residual function, protein binding restricted the peritoneal indican and p-cresol sulfate clearances to 0.3 ± 0.1 ml/min, as compared to the peritoneal urea clearance of 5.5 ± 1.1 ml/min. The urinary indican and p-cresol sulfate clearances of 2.7 ± 2.5 and 1.3 ± 1.0 ml/min were closer to the urinary urea clearance of 3.9 ± 2.2 ml/min, reflecting the superior ability of native kidney function to clear bound solutes. Urinary clearance thus provided the majority of the total indican and p-cresol sulfate clearances of 3.0 ± 2.5 and 1.6 ± 1.0 ml/min in patients with residual function but the minority of total urea clearance of 9.4 ± 2.2 ml/min. Loss of residual function lowered the total clearances for indican and p-cresol sulfate to 0.5 ± 0.2 and 0.4 ± 0.2 ml/min, whereas the urea clearance fell only slightly. However there was only a modest increase in the plasma indican level and no increase in the plasma p-cresol sulfate level in patients with no residual function because reduction in the daily removal of these solutes accompanied the reduction in their total clearance rates.

Conclusions: Reduction in the removal of indican and p-cresol sulfate kept plasma levels from rising markedly when residual function was lost.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.